<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://http://dspace.unitus.it:80">
    <title>Unitus DSpace</title>
    <link>http://http://dspace.unitus.it:80</link>
    <description>The DSpace digital repository system captures, stores, indexes, preserves, and distributes digital research material.</description>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://hdl.handle.net/2067/1455" />
        <rdf:li rdf:resource="http://hdl.handle.net/2067/1485" />
      </rdf:Seq>
    </items>
    <dc:date>2013-05-22T11:40:05Z</dc:date>
  </channel>
  <item rdf:about="http://hdl.handle.net/2067/1455">
    <title>Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices</title>
    <link>http://hdl.handle.net/2067/1455</link>
    <description>Title: Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices
Authors: Cammalleri, Maurizio; Cervia, Davide; Langenegger, Daniel; Liu, Yanqiang; Dal Monte, Massimo; Hoyer, Daniel; Bagnoli, Paola
Abstract: Somatostatin-14 (SRIF) reduces hippocampal epileptiform activity but the contribution of its specific receptors (sst1-5) is poorly understood. We have focused on sst1 and sst2 role in mediating SRIF modulation of epilepsy using hippocampal slices of wild type (WT) and sst1 or sst2 knock out (KO) mice. Recordings of epileptiform discharge induced by Mg2+-free medium with 4-aminopyridine were performed from the CA3 region before and after the application of SRIF compounds. In WT mice, SRIF and the sst1 agonist CH-275 reduce epilepsy whereas sst1 blockade with its antagonist SRA-880 increases bursting discharge. Activation of sst2 does not affect bursting frequency unless its agonist octreotide is applied with SRA-880, indicating that sst1 masks sst2-mediated modulation of epilepsy. In sst1 KO mice: i. bursting frequency is lower than in WT; ii. SRIF, CH-275 and SRA-880 are ineffective on epilepsy; iii. octreotide is also devoid of effects, whereas blockade of sst2 with the antagonist D-Tyr8 Cyn 154806 increases bursting frequency. In sst2 KO mice, SRIF ligand effects are similar to those in WT. In the whole hippocampus of sst1 KO mice, sst2 mRNA, protein and binding are higher than in WT and RT-PCR of the CA3 subarea confirms an increase of the sst2 messenger. We conclude that sst1 mediates inhibitory actions of SRIF and that interactions between sst1 and sst2 may prevent sst2 modulation of epilepsy. We suggest that, in sst1 KO mice, activation of over-expressed sst2 reduces bursting frequency, indicating that sst2 density represents the rate-limiting factor for sst2-mediated modulation of epilepsy.
Description: L'articolo è disponibile sul sito dell'editore http://onlinelibrary.wiley.com/</description>
    <dc:date>2003-12-31T23:00:00Z</dc:date>
  </item>
  <item rdf:about="http://hdl.handle.net/2067/1485">
    <title>Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus</title>
    <link>http://hdl.handle.net/2067/1485</link>
    <description>Title: Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus
Authors: Ristori, Chiara; Cammalleri, Maurizio; Martini, Davide; Pavan, Barbara; Liu, Yanqiang; Casini, Giovanni; Dal Monte, Massimo; Bagnoli, Paola
Abstract: The cAMP pathway is major signal transduction system involved in hippocampal neurotransmission. Recently, the peptide somatostatin-14 (SRIF) has emerged as a key signal that, by activating its receptors, inhibits epileptiform bursting in the mouse hippocampus. Little is known on transduction mechanisms which may mediate SRIF function in native cell/tissues. Using a well established model of epileptiform activity induced by Mg2+-free medium with 4-aminopyridine (0 Mg2+⁄4-AP) in mouse hippocampal slices, we demonstrated that PKA-related signaling is upregulated by hippocampal bursting and that treatment with SRIF normalizes this upregulation. We also demonstrated that the SRIF-induced inhibition of PKA impairs phosphorylation of the NMDA receptor subunit NR1. Extracellular recordings of the 0 Mg2+⁄4-AP-induced hippocampal discharge from the CA3 region demonstrated that treating slices with compounds which interfere with PKA activity prevent SRIF inhibition of epileptiform bursting. Our results suggest that SRIF modulation of hippocampal activity may involve PKA-related signaling.
Description: L'articolo è disponibile sul sito dell'editore http://www.springerlink.com</description>
    <dc:date>2007-12-31T23:00:00Z</dc:date>
  </item>
</rdf:RDF>

